Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 safety and pharmacokinetic study of intranasal melatonin suspension in healthy adult men
RBR-3t7fcyPhase 1Not yet recruiting
- Sponsor
- Cosmed Indústria de Cosméticos e Medicamentos
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of melatonin in Insomnia (5 arms), sponsored by Cosmed Indústria de Cosméticos e Medicamentos. Primary endpoints: Safety and Pharmacokinetics. Planned start Dec 2017; status: not yet recruiting.
02
Drugs
melatonin
03
Conditions
Insomnia
Beyond the preview
Go deeper on RBR-3t7fcy.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-3t7fcy.